Eurasian Journal of Medical and Natural Sciences 5-jild 2-son (2025) · 118–122-betlar

NEUROTRANSMITTER ASPECTS OF ACHIEVING REMISSION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER

Khasanova, Kamilla, Egamberdieva, Zulfera, Ankabayev, Shavkat, Mamurova, Mavludakhon, Kasimov, Arslanbek

DOI: 10.5281/zenodo.14850960 · Manbada o'qish →

Annotatsiya

Major Depressive Disorder (MDD) represents one of the most significant challenges in modern psychiatry, affecting approximately 280 million people globally and constituting a leading cause of disability worldwide. Despite advances in treatment approaches, achieving and maintaining remission remains a complex clinical challenge, with only about 30-40% of patients achieving full remission after initial treatment.

Major depressive disorder, neurotransmitters, remission, serotonin, norepinephrine, dopamine, neurotransmitter systems, synaptic plasticity, neurobiological markers, treatment response, monoamines, neural circuits.

Metadata manbasi: jurnal OAI-PMH arxivi · Sindex to'liq matnni saqlamaydi, manbaga havola beradi.